Drugmaker Bristol-Myers Squibb said Monday it will work with Dutch biotechnology company uniQure to develop gene therapies for cardiovascular diseases.
The companies will focus first on a treatment for congestive heart failure. They said uniQure could get more than $2.2 billion from the deal in total, and Bristol-Myers Squibb will also take a minority stake in the company.
22:46 8 takeaways from Apple’s Q4 2016 earnings call12
16:51 Scottrade Sale Nearly Doubles Owner’s Wealth to $4 Billion11
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T6
18:04 US stocks hold higher after release of Fed's Beige Book; energy rises 2%1